Phase Genomics
Phase Genomics provides ultra-long-range genome sequencing technology and computational tools for researchers in genomics, cytogenetics, oncology, and microbiology. Its products enable genomic profiling, metagenome deconvolution, viral genome reconstruction, and detection of chromosomal abnormalities in a variety of organisms. The organization aims to empower scientists with advanced genomic tools to accelerate discoveries in health, agriculture, and environmental research.
Facts
- HQ
- Seattle, WA 98109
- Sectors
- Biotechnology Research
- Founded
- 2015
- Type
- Corporation Seattle business license
- Employees
- 15
- Registered name
- Phase Genomics Inc Seattle business license
- Stage
- startup
- Members see funding amounts. .
- Founders
- Ivan Liachko, Jay Shendure, PhD, Maitreya Dunham, PhD
Is this your organization? Claim it
Phase Genomics Secures $2.5M to Develop AI Platform for Detecting Cancer Chromosomal Aberrations
Seattle startup Phase Genomics received $2.5 million in funding, including $2 million from the U.S. National Cancer Institute and $500,000 from Washington state's Andy Hill CARE Fund, to advance its AI-driven platform that detects chromosomal aberrations in cancer. The funding supports projects analyzing tumor samples to develop predictive scores for cancers like acute myeloid leukemia and colorectal cancer.
AI, startups, and Star Wars: Highlights from the GeekWire Awards
The theme at this week's GeekWire Awards was Star Wars, but we didn't need to go to a galaxy far, far away to find the force that promises to reshape the technology industry. The game-changing potential of AI was on the minds of many finalists and attendees, and integral to the business models of many of the companies featured on stage. This episode features conversations with finalists and attendees about the economy, artificial intelligence, and more ... plus lots of cool tech along the way. GeekWire Awards 2023 revealed: Community honors top innovation in Pacific Northwest tech Seattle Seahawks legend…
Grin Lord, CEO of Seattle’s mpathic, Finalist for Startup CEO of the Year at 2023 GeekWire Awards for Empathy-Driven Communication Software
Grin Lord, CEO and co-founder of Seattle startup mpathic, specializes in using empathy to improve corporate communication and is a finalist for Startup CEO of the Year at the 2023 GeekWire Awards. Her company applies machine learning to analyze conversations and foster empathy across industries such as insurance, healthcare, and human resources.
By Phase Genomics
Phase Genomics Announces ProxiMeta™ Starter and Elite Bundles, Cites Grants, Awards, and Funding Rounds Supporting Hi-C Metagenomics
Phase Genomics highlights recent milestones and coverage about its Hi-C genome-resolved metagenomics technology, including new product bundles, multiple grants and funding rounds, awards, leadership moves, and applications reported in scientific and popular media.
People
-
Ivan Liachko Founder & CEO
-
Kayla Young Executive, Executive Officer, COO
Online
Questions about Phase Genomics
What is Phase Genomics?
Phase Genomics is a startup that provides ultra-long-range genome sequencing technology and computational tools for genomics, cytogenetics, oncology, and microbiology researchers. It is based in Seattle, WA 98109.
What is Phase Genomics known for?
Phase Genomics is known for tools that enable genomic profiling, metagenome deconvolution, viral genome reconstruction, and detection of chromosomal abnormalities.
What has Phase Genomics been in the news for?
GeekWire reported in August 2023 on Phase Genomics developing an AI platform for detecting cancer chromosomal aberrations.
Who are the people behind Phase Genomics?
Ivan Liachko is founder and CEO of Phase Genomics. Kayla Young is COO, executive, and executive officer.
Who invested in Phase Genomics, and how much has it raised?
Members of Seattle Flow see Phase Genomics' funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Phase Genomics based?
Phase Genomics is based in Seattle, WA 98109.